Skip to main content
. 2024 Jun 28;56(8):1184–1198. doi: 10.3724/abbs.2024107

Figure 1 .


Figure 1

Ligands of siglecs and the effects on immune cells mediated by their interactions

(A) Structures of siglec7/9/10/15 and their binding ligands on tumor cells or target cells. (B) Potential effects on immune cells caused by the interaction between siglec 7/9/10/15 and glycosylated ligands on tumor cells.